Regenerative toxicology: the role of stem cells in the development of chronic toxicities

Abstract

Introduction: Human stem cell lines and their derivatives, as alternatives to the use of animal cells or cancer cell lines, have been widely discussed as cellular models in predictive toxicology. However, the role of stem cells in the development of long-term toxicities and carcinogenesis has not received great attention so far, despite growing evidence indicating the relationship of stem cell damage to adverse effects later in life. However, testing this in vitro is a scientific/technical challenge in particular due to the complex interplay of factors existing under physiological conditions. Current major research programs in stem cell toxicity are not aiming to demonstrate that stem cells can be targeted by toxicants. Therefore, this knowledge gap needs to be addressed in additional research activities developing technical solutions and defining appropriate experimental designs.

Areas covered: The current review describes selected examples of the role of stem cells in the development of long-term toxicities in the brain, heart or liver and in the development of cancer.

Expert opinion: The presented examples illustrate the need to analyze the contribution of stem cells to chronic toxicity in order to make a final conclusion whether stem cell toxicities are an underestimated risk in mechanism-based safety assessments. This requires the development of predictive in vitro models allowing the assessment of adverse effects to stem cells on chronic toxicity and carcinogenicity.

Keywords::

• acetaminophen
• benzene
• carcinogenicity
• chronic toxicity
• doxorubicin
• propofol
• stem cells

Acknowledgments

The authors would like to thank Ian Cotgreave, Chair of the SEURAT-1 Scientific expert panel for fruitful discussions. D Canovas-Jorda, J Louisse, F Pistollato, and D Zagoura have contributed equally to this work.

Notes

This box summarizes key points contained in the article.